Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | APP | P05067 | 4/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL1867515 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL157250 | 0.97 | TSHR (0.59) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL10588750 | 0.91 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| Diethylene Glycol Monoethyl Ether SCHEMBL28089667 | 0.91 | ALDH1A1 (0.64) | MEN1KMT2ATSHRMAPK1THRB | |
| Triethylene Glycol SCHEMBL596544 | 0.89 | MEN1 (0.48) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL28879226 | 0.87 | TSHR (0.71) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL28076111 | 0.87 | TSHR (0.71) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL28752322 | 0.85 | TSHR (0.46) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL28335739 | 0.85 | MEN1 (0.73) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL17789960 | 0.84 | MEN1 (0.48) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028500-A1 | SEALING FILM COMPOSITIONS FOR SEALING MICROCELLS OF ELECTROOPTIC DEVICES | E INK CORP (US) | 2026-01-29 | — | — | US | claimed |
| US-12497534-B2 | Sealing film compositions for sealing microcells of electro-optic devices | E INK CORPORATION (US) | 2025-12-16 | — | — | US | claimed |
| EP-3993130-B1 | LITHIUM-SULFUR BATTERY ELECTROLYTE AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2025-11-26 | — | — | EP | claimed |
| EP-4044314-B1 | ELECTROLYTE FOR LITHIUM-SULFUR BATTERY, AND LITHIUM-SULFUR BATTERY INCLUDING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2025-09-24 | — | — | EP | claimed |
| EP-4138169-B1 | LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION LTD (KR) | 2025-09-10 | — | — | EP | claimed |
| EP-3985776-B1 | LITHIUM-SULFUR BATTERY ELECTROLYTE AND LITHIUM-SULFUR BATTERY INCLUDING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2025-08-20 | — | — | EP | claimed |
| US-12341157-B2 | Lithium-sulfur battery electrolyte and lithium-sulfur battery including same | LG ENERGY SOLUTION, LTD. (KR) | 2025-06-24 | — | — | US | claimed |
| EP-4210145-B1 | ELECTROLYTE FOR A LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY COMPRISING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2025-03-19 | — | — | EP | claimed |
| US-12183889-B2 | Lithium-sulfur battery electrolyte and lithium-sulfur battery comprising same | LG ENERGY SOLUTION, LTD. (KR) | 2024-12-31 | — | — | US | claimed |
| CN-114556651-B | Electrolyte for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG新能源 | 2024-11-01 | — | — | CN | claimed |
| CN-102453148-B | Olefin polymerization catalyst component, olefin polymerization catalyst and olefin polymerization method | CHINA PETROLEUM & CHEMICAL | 2014-04-02 | — | — | CN | claimed |
| EP-2703379-A1 | 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME | Nippon Carbide Industries Co., Inc. (JP) | 2014-03-05 | — | — | EP | claimed |
| US-20140058136-A1 | 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME | NIPPON CARBIDE INDUSTRIES CO., INC. (JP) | 2014-02-27 | — | — | US | claimed |
| US-6743284-B2 | COMPRISES WATER, DYE, AND POLYOXYALKYLENE GLYCOL ALKYLETHERS; FOR INK-JET PRINTING | BROTHER KOGYO KABUSHIKI KAISHA (JP) | 2004-06-01 | — | — | US | claimed |
| US-20030225144-A1 | Novel crystalline forms of a factor Xa inhibitor | AVENTIS PHARMACEUTICALS INC. | 2003-12-04 | — | — | US | claimed |
| WO-2002028836-A9 | NOVEL CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR | AVENTIS PHARMA INC (US) | 2003-11-20 | — | — | WO | claimed |
| EP-1326838-A1 | NOVEL CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR | Aventis Pharmaceuticals Inc. (US) | 2003-07-16 | — | — | EP | claimed |
| US-20020043179-A1 | Printing ink composition | BROTHER KOGYO KABUSHIKI KAISHA (JP) | 2002-04-18 | — | — | US | claimed |
| WO-2002028836-A1 | NOVEL CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR | AVENTIS PHARMACEUTICALS, INC. (US) | 2002-04-11 | — | — | WO | claimed |
| US-4031158-A | LUBRICANT, COSMETICS, TEXTILES | LION FAT & OIL CO., LTD. (JA) | 1977-06-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140058136-A1 | 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME | OR10J3, CUTA, OR51E2 | MEN1 1896/4885KMT2A 748/4885TSHR 4682/4885 |
| US-20030225144-A1 | Novel crystalline forms of a factor Xa inhibitor | SERPINC1, F12, TFPI | MEN1 1651/4885KMT2A 4091/4885TSHR 2622/4885 |
| US-20260028500-A1 | SEALING FILM COMPOSITIONS FOR SEALING MICROCELLS OF ELECTROOPTIC DEVICES | GJA1, GJB2, EPCAM | MEN1 929/4885KMT2A 4517/4885TSHR 3526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.